Bio-Techne Corp (TECH)

Financial leverage ratio

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Total assets	US$ in thousands	2,703,870	2,721,170	2,730,750	2,755,360	2,638,690	2,599,700	2,363,400	2,350,720	2,294,800	2,299,890	2,304,850	2,270,190	2,262,960	2,084,640	2,067,870	2,053,100	2,027,590	1,999,020	1,998,420	1,925,030
Total stockholders’ equity	US$ in thousands	2,068,850	2,014,380	1,963,560	1,997,750	1,966,520	1,889,690	1,827,110	1,751,150	1,701,770	1,714,380	1,702,990	1,639,360	1,562,970	1,539,450	1,521,920	1,439,280	1,381,190	1,291,270	1,323,350	1,174,220
Financial leverage ratio		1.31	1.35	1.39	1.38	1.34	1.38	1.29	1.34	1.35	1.34	1.35	1.38	1.45	1.35	1.36	1.43	1.47	1.55	1.51	1.64

June 30, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,703,870K ÷ $2,068,850K
= 1.31

Based on the financial leverage ratio data provided for Bio-Techne Corp, we observe fluctuations in the ratio over the past few quarters. The financial leverage ratio measures the extent to which a company is using debt to finance its operations and assets. A higher financial leverage ratio indicates higher levels of debt relative to equity.

From December 2019 to March 2020, the financial leverage ratio increased from 1.51 to 1.55, suggesting a slight increase in the company's reliance on debt during this period. However, this ratio started to decrease in the subsequent quarters until December 2020, when it reached its lowest point at 1.36.

Subsequently, from December 2020 to September 2022, the financial leverage ratio showed a fluctuating but relatively stable trend between 1.29 and 1.35. This indicates that Bio-Techne Corp maintained a fairly consistent debt-to-equity mix during this period.

From December 2022 to March 2024, the financial leverage ratio increased from 1.29 to 1.39, highlighting a potential increase in the company's debt levels compared to equity. This uptrend in the ratio could indicate a shift towards a higher reliance on debt financing in recent quarters.

Overall, the financial leverage ratio data for Bio-Techne Corp suggests a varying degree of reliance on debt over the analyzed periods, with some fluctuations indicating changes in the company's capital structure and financing strategies. It will be important for stakeholders to monitor these trends to assess the company's risk profile and financial health.